Results 241 to 250 of about 749,882 (394)
CYTOCHEMICAL CHANGES DURING NORMAL GROWTH AND COMPENSATORY HYPERTROPHY OF THE RAT KIDNEY
, 1955 N. B. Kurnick
openalex +1 more source
ELECTROCARDIOGRAPHIC EVIDENCE OF ABNORMAL VENTRICULAR PREPONDERANCE AND OF AURICULAR HYPERTROPHY [PDF]
, 1918 Paul D. White, Arlie V. Bock
openalex +1 more source
Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues
ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang +7 more
wiley +1 more source
Computational modelling of the impact of anatomical changes on ECGs in left ventricular hypertrophy. [PDF]
J PhysiolKariman M +5 more
europepmc +1 more source
The so‐called compensatory hypertrophy of the testicle after unilateral castration1
, 1922 Alexander Lipschütz
openalex +2 more sources
A CASE OF CONGENITAL HYPERTROPHY OF THE PYLORUS IN AN INFANT; [PDF]
, 1899 FrederickE. Batten
openalex +1 more source
Biomarkers of lung congestion and injury in acute heart failure
ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi +9 more
wiley +1 more source
Deciphering the Role of Different Ceramide Synthases in the Human Cardiomyocyte Hypertrophic Response. [PDF]
MetabolitesWiley AM +7 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler +4 more
wiley +1 more source